High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-08
DOI
10.1038/srep18995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma
- (2015) Charupong Saengboonmee et al. Cancer Epidemiology
- Metformin does not improve survival of cholangiocarcinoma patients with diabetes
- (2015) Zhen Yang et al. HEPATOLOGY
- Metformin: A Novel but Controversial Drug in Cancer Prevention and Treatment
- (2015) Xinbing Sui et al. MOLECULAR PHARMACEUTICS
- Impact of high glucose on metastasis of colon cancer cells
- (2015) Cheng-Yao Lin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma
- (2015) Xingming Jiang et al. Oncotarget
- Luteolin Arrests Cell Cycling, Induces Apoptosis and Inhibits the JAK/STAT3 Pathway in Human Cholangiocarcinoma Cells
- (2014) Ploypailin Aneknan et al. Asian Pacific Journal of Cancer Prevention
- STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression
- (2014) Hasaya Dokduang et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- High Glucose Level Promotes Migration Behavior of Breast Cancer Cells through Zinc and Its Transporters
- (2014) Tomoka Takatani-Nakase et al. PLoS One
- Increased EphB2 expression predicts cholangiocarcinoma metastasis
- (2014) Walaiporn Khansaard et al. TUMOR BIOLOGY
- Hyperglycemia, a Neglected Factor during Cancer Progression
- (2014) Wanxing Duan et al. Biomed Research International
- Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
- (2013) Rui-qing Liu et al. Cancer Cell International
- Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
- (2013) K M Biernacka et al. ENDOCRINE-RELATED CANCER
- Pivotal role of oxidative stress in tumor metastasis under diabetic conditions in mice
- (2013) Mai Ikemura et al. JOURNAL OF CONTROLLED RELEASE
- A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
- (2013) Custodia García-Jiménez et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells
- (2013) Chanchal Gupta et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling Pathway
- (2013) Laddawan Senggunprai et al. PHYTOTHERAPY RESEARCH
- Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR
- (2013) Rebecca Lopez et al. PLoS One
- Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
- (2013) Takanori Hosokawa WORLD JOURNAL OF GASTROENTEROLOGY
- Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma
- (2012) Sun Mi Hong et al. CLINICAL & EXPERIMENTAL METASTASIS
- Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk
- (2012) Roongruedee Chaiteerakij et al. HEPATOLOGY
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
- (2012) William C. Palmer et al. JOURNAL OF HEPATOLOGY
- Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
- (2012) Ana Chocarro-Calvo et al. MOLECULAR CELL
- Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer
- (2012) J. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diabetes mellitus and increased risk of cholangiocarcinoma
- (2011) Wei Jing et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Hyperglycemia enhances the invasive and migratory activity of pancreatic cancer cells via hydrogen peroxide
- (2011) Ma ONCOLOGY REPORTS
- The current status of opisthorchiasis and clonorchiasis in the Mekong Basin
- (2011) Paiboon Sithithaworn et al. PARASITOLOGY INTERNATIONAL
- Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand
- (2011) Eimorn Mairiang et al. PARASITOLOGY INTERNATIONAL
- Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation
- (2010) K Masur et al. BRITISH JOURNAL OF CANCER
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells
- (2010) Han Liu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Epigenetic phenomena linked to diabetic complications
- (2010) Luciano Pirola et al. Nature Reviews Endocrinology
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started